Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Treasury Shares (2020)

Historic Treasury Shares for Summit Therapeutics (SMMT) over the last 1 years, with Q4 2017 value amounting to $30.55.

  • Summit Therapeutics' Treasury Shares changed N/A to $30.55 in Q4 2017 from the same period last year, while for Dec 2017 it was $30.55, marking a year-over-year change of. This contributed to the annual value of $30.55 for FY2017, which is N/A changed from last year.
  • Summit Therapeutics' Treasury Shares amounted to $30.55 in Q4 2017.
  • Over the past 5 years, Summit Therapeutics' Treasury Shares peaked at $30.55 during Q4 2017, and registered a low of $30.55 during Q4 2017.